Fourpath Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $722K | Buy |
+18,806
| New | +$722K | 0.11% | 112 |
|
|
2024
Q4 | – | Sell |
-5,276
| Closed | -$216K | – | 460 |
|
|
2024
Q3 | $216K | Buy |
+5,276
| New | +$216K | 0.04% | 213 |
|
|
2022
Q3 | – | Sell |
-4,082
| Closed | -$222K | – | 120 |
|
|
2022
Q2 | $222K | Sell |
4,082
-30
| -0.7% | -$1.63K | 0.14% | 123 |
|
|
2022
Q1 | $224K | Hold |
4,112
| – | – | 0.09% | 138 |
|
|
2021
Q4 | $227K | Buy |
+4,112
| New | +$227K | 0.09% | 151 |
|